Estimations des analystes de Wall Street pour Spyre Therapeutics, Inc. (SYRE): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-03 | $-0.80 | ||
| 2026-08-04 | $-0.36 | $-0.76 | +52.6% |
| 2026-05-05 | $-0.74 | $-0.66 | -12.1% |
| 2026-02-19 | $-0.70 | $-0.66 | -6.1% |
| 2025-11-04 | $-0.15 | $-0.76 | +80.3% |
| 2025-08-05 | $-0.49 | $-0.73 | +32.9% |
| 2025-05-08 | $-0.74 | $-0.84 | +11.9% |
| 2025-02-28 | $-0.81 | $-0.89 | +9.0% |
Ratios de valorisation
| Prix / Valeur comptable | 7.02 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $4.6M | $5.2M | $3.9M | 0 | 0 | $18.7M | $2.3M | $886000 | 0 | 0 |
| Coût des Ventes | 0 | 0 | 0 | $901000 | $1.6M | 0 | 0 | 0 | 0 | $171.7M |
| Marge Brute | 0 | 0 | 0 | -$901000 | -$1.6M | $18.7M | $2.3M | $886000 | 0 | -$171.7M |
| R&D | $18.1M | $22.8M | $36.7M | $64.6M | $59.6M | $57.1M | $58.6M | $89.5M | $162.8M | $171.7M |
| Frais Généraux | $8.4M | $10.1M | $12.6M | $14.8M | $20.2M | $27.3M | $28.5M | $39.9M | $45.8M | $47.9M |
| Charges Opérationnelles | $26.5M | $32.9M | $49.4M | $79.4M | $79.9M | $84.4M | $87.1M | $243.2M | $208.6M | $37.9M |
| Résultat Opérationnel | -$21.9M | -$27.7M | -$45.5M | -$80.3M | -$81.5M | -$65.6M | -$84.8M | -$242.3M | -$208.6M | -$209.6M |
| EBITDA | -$21.8M | -$27.4M | -$45.2M | -$77.4M | -$79.3M | -$64.1M | -$82.0M | -$127.6M | -$208.0M | -$209.6M |
| Charges d'Intérêt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$21.7M | -$27.2M | -$44.3M | -$78.3M | -$80.9M | -$65.7M | -$84.0M | -$338.8M | -$208.0M | -$155.2M |
| Impôts | 0 | 0 | 0 | 0 | 0 | $141000 | -$136000 | -$26000 | $51000 | -$15000 |
| Résultat Net | -$21.7M | -$27.2M | -$44.3M | -$78.3M | -$80.9M | -$65.8M | -$83.8M | -$338.8M | -$208.0M | -$155.2M |
| BPA | $-55.40 | $-45.01 | $-53.25 | $-61.23 | $-37.89 | $-25.02 | $-24.86 | $-46.15 | $-3.18 | $-1.98 |
| BPA Dilué | $-55.40 | $-45.01 | $-53.25 | $-61.23 | $-37.89 | $-25.02 | $-24.86 | $-46.15 | $-3.18 | $-1.98 |
| Actions en Circulation (Diluées) | $391669 | $605127 | $832902 | $1.3M | $2.1M | $2.6M | $3.4M | $6.9M | $47.0M | $64.1M |
Prix
| Prix | $91.17 |
| Capitalisation | $7.9B |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ABCL · ARDX · CLDX · IMNM · MAZE · NTLA · PHVS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de SYRE: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions